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Abstract
Background: To study the diabetes related CVD risk between men and women of different ages.
Methods:  Hazards ratios (HRs) (95%CI) for acute CHD and ischaemic stroke events were
estimated based on data of Finnish and Swedish cohorts of 5111 women and 4167 men.
Results: 182 (3.6%) women and 348 (8.4%) men had CHD and 129 (2.5%) women and 137 (3.3%)
men ischaemic stroke events. The multivariate adjusted HRs for acute CHD at age groups of 40–
49, 50–59 and 60–69 years were 1.00 (1.94), 1.78 (4.23), 3.75 (8.40) in women (men) without
diabetes and 4.35 (5.40), 5.49 (9.54) and 8.84 (13.76) in women (men) with diabetes. The
corresponding HRs for ischaemic stroke were 1.00 (1.26), 2.48 (2.83) and 5.17 (5.11) in women
(men) without diabetes and 4.14 (4.91), 3.32 (6.75) and 13.91 (18.06) in women (men) with
diabetes, respectively.
Conclusion: CHD risk was higher in men than in women but difference reduced in diabetic
population. Diabetes, however, increased stroke risk more in men than in women.
Background
Coronary heart disease (CHD) and stroke are common
causes of disability and death [1]. Diabetes mellitus has
been found to increase the risk of CHD and stroke events
both in women and in men [2-8]. A more markedly
increased relative risk for CHD [2,4,5] and stroke [6-8] has
been found in diabetic women compared with diabetic
men, however the reported magnitudes vary greatly
between studies [2,7,8].
CHD and stroke are generally discussed as two diseases
with similar etiology caused by atherosclerotic vascular
disease. While CHD and stroke have been shown to share
some known cardiovascular disease (CVD) risk factors [1],
some common CHD risk factors, such as serum total cho-
lesterol [9,10] levels have not been indicated to have an
association with increased risk of stroke [10,11]. Also,
MONICA study reported CHD rates to decrease and stroke
rates to increase in some populations while in other pop-
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ulations the opposite was observed [12]. This may imply
different underlying mechanisms and etiology for the two
diseases. To what extent diabetes, gender and age affect
the development of CHD and stroke is not fully eluci-
dated. Furthermore, little is known about the magnitude
of the association between CVD risk factors and the risk of
CHD and ischaemic stroke.
The purpose of the present study was to estimate the
impact of diabetes and gender and age on the develop-
ment of CHD and ischaemic stroke and to find out to
what extent the known CVD risk factors affect the devel-
opment of these diseases.
Participants and methods
This sub-data analysis of the DECODE study comprised of
9278 participants, 5111 (55.1%) women and 4167
(44.9%) men, from 7 cohorts from Finland and Sweden.
Individuals participating at the baseline survey were fol-
lowed up till 2006 and 2004 for the Finnish and the Swed-
ish cohorts respectively. The age range of the study
population varied from 40 to 69 years. Measurements for
fasting plasma glucose and 75 g 2-h oral glucose tolerance
test, body mass index (BMI), total serum cholesterol, HDL
cholesterol, systolic and diastolic blood pressure, antihy-
pertensive treatment, and smoking status were available
for each study population included in the current analysis.
Definition of the clinical end points
Acute CHD and ischaemic stroke events (both fatal and
non-fatal) were used as end points. Individuals with a his-
tory of CVD before the baseline survey were excluded
from the analysis. The information on CVD mortality and
morbidity were collected from National Causes of Death
Register and the National Hospital Discharge Registry and
ascertained by using a computerized record linkage of
individual ID numbers of each of the individuals partici-
pating in the study. The acute CHD and ischaemic stroke
events were coded according to the International Classifi-
cation of Diseases (8th, 9th revisions and 10th revision)
with codes 410 to 414 and I20 to I25 for fatal and codes
410 to 411 and I21 to I22 for non-fatal CHD and codes
433, 434 and I63 for ischaemic stroke. Cases of haemor-
rhagic stroke were checked and not included in the final
data analysis due to the small numbers. Diabetes was
defined as either a history of diabetes at baseline or FPG
levels >= 7.0 mmol/L and/or 2-h PG levels >= 11.1 mmol/
L. Participants who had emigrated and whose vital status
could not be confirmed were treated as censored cases.
The local Ethics Committees had approved each individ-
ual study plan and the data analysis plan was approved by
the Ethics Committee of the National Public Health Insti-
tute, Finland.
Statistical methods
The data analysis was carried out by using SPSS for Win-
dows version 15.0. Event rates per 1000 person-years for
CHD and ischaemic stroke were calculated for per 10-year
age-groups (40–69 years), gender and diabetic status. Dif-
ferences between women and men within each of the age
categories were estimated using the 2 test. Univariate
analysis of variance was used to estimate the trend in car-
diovascular risk factors with aging. Hazard ratios with
95% confidence intervals for acute CHD or ischaemic
stroke events were estimated using Cox proportional haz-
ards model. The analysis was adjusted for study, hyperten-
sion status ( 140/90 mmHg or treatment), body mass
index (BMI), total serum cholesterol, HDL-cholesterol
and smoking status. BMI was calculated by using weight
in kilograms divided by the square of height in meters and
smoking status was categorized as current smoker, ex-
smoker or nonsmoker. Non-diabetic women aged 40–49
years were used as the reference group for risk calcula-
tions.
Results
The demographic data at baseline and the follow-up
information in each cohort are shown in table 1. The max-
imum length of follow-up varied between 4.9 to 20.6
years in women and in men. During this period 182
(3.6%) women and 348 (8.4%) men had acute CHD and
129 (2.5%) women and 137 (3.3%) men acute ischaemic
stroke events. A total of 384 (7.5%) women and 442
(10.6%) men had diabetes (both diagnosed and undiag-
nosed) (table 1). The characteristics of subjects according
to age groups, diabetes status and gender are given in table
2. In the non-diabetic population, the means of BMI and
total cholesterol as well as the prevalence of hypertension
were all higher in men than in women in the youngest age
group, but the gender differences leveled off with increas-
ing age and became even or lower in men than in women
in the oldest age group. In non-diabetic women and men
the increasing trend with aging was significant (p = 0.001)
for BMI, cholesterol and hypertension (table 2). Diabetic
women were, however, more obese than diabetic men in
all ages. HDL-cholesterol was higher in women than in
men and smoking was more common in men than in
women in all ages regardless of the diabetic status. The
increasing trend in known CVD risk factors with aging in
diabetic individuals was significant only for total choles-
terol levels in women.
The event rates for acute CHD and ischaemic stroke were
higher in men with and without diabetes compared with
their female counterparts. The gender difference for CHD
was larger in the non-diabetic than in the diabetic individ-
uals, whereas this was not as substantial for ischaemic
stroke as for CHD (table 3). The multivariate-adjusted
hazard ratios of acute CHD events increased with agingCardiovascular Diabetology 2009, 8:17 http://www.cardiab.com/content/8/1/17
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and diabetes, and were higher in men both with and with-
out diabetes compared with age matched women, but the
gender difference was diminished in diabetic individuals.
In contrast, the gender difference with the ischaemic
stroke was enlarged in the diabetic population because
the risk of ischaemic stroke increased more in diabetic
men than in diabetic women (table 3). Diabetes and aging
were associated with an increased risk of acute CHD and
ischaemic stroke events in both genders, however diabetes
was a stronger risk predictor for the risk of ischaemic
stroke than for CHD (table 4). Cholesterol predicted the
risk of acute CHD, but not ischaemic stroke event, in both
genders. Hypertension increased the acute CHD and
ischaemic stroke risk, and BMI CHD risk only in women
(table 4).
Discussion
In the present study we found that both non-diabetic and
diabetic men had a higher risk of CHD than their female
counterparts, but the gender difference was smaller in the
diabetic than in the non-diabetic populations. In contrast,
diabetic men had higher rates of ischaemic stroke events
than diabetic women but the event rates did not differ
much in the non-diabetic population. Diabetes conveyed
a higher CHD risk in women but ischaemic stroke risk in
men.
Diabetes is a well known risk factor for CHD [13-15] and
stroke [16,7,8] in both genders. CHD and stroke are often
discussed as diseases of the same family caused by athero-
sclerotic vascular disease. While this would implicate
shared risk factors, studies have indicated some differ-
ences in risk factor profiles for the two diseases [9-11].
Also, the patterns of the trend of CHD and stroke inci-
dence have been shown to vary in a population [12,17].
In the present study the diabetes attributable risk was
higher to the acute ischaemic stroke than to the acute
CHD in men, whereas it was similar in women. Previous
studies have reported diabetes to increase the risk of CHD
[2,4,5] and stroke [6-8] more markedly in women than in
men. These studies have, however, used non-diabetic
women and non-diabetic men as reference groups for
women and for men, respectively, when they calculated
the relative risk for diabetic individuals. Since the non-
diabetic young men had much higher CHD and stroke
risk than non-diabetic women, the relative risk increase
due to diabetes in men tended to be lower than that in
women. To make it comparable between women and
men, we have used non-diabetic women in the youngest
age group as reference for both women and men of all
other age groups. We found the relative risk was higher in
men than in women both with and without diabetes, even
though the gender difference for the CHD risk was dimin-
ished in diabetic individuals. Contradictory to the previ-
ous reports on stroke we found in the present study a
more markedly increased risk of acute ischaemic stroke
events in diabetic men compared with diabetic women.
But whether this is true for haemorrhagic stroke or for the
subtypes of ischaemic stroke cannot be examined in the
current study due to the low number of the haemorrhagic
stroke events and inability of further classification of indi-
viduals into subtypes of the ischaemic stroke. Previous
studies with both ischaemic and haemorrhagic stroke
showed a higher relative stroke risk in diabetic women
than in diabetic men [6-8], and it was also reported that
the risk for certain subtypes of ischaemic or haemorrhagic
stroke differed between women and men [18,19]. This
might have affected the observations and needs to be
explored in more detail in the future.
Non-diabetic men had higher rates of smoking, hyperten-
sion and abnormalities of lipid profiles than non-diabetic
women; which could partly explain the higher CHD risk
in non-diabetic men than in non-diabetic women. Also,
other factors such as the menopause status [20] and the
management of risk factors [20,21] may have contributed
to the observed gender difference in CHD and ischemic
stroke incidence. Obesity and cholesterol levels were
higher in diabetic women than diabetic men, which may
partly have reduced the gender difference in CHD risk in
diabetic population. Aging seemed a strong risk predictor
for CHD in both women and men, particularly for men.
This may to some extent be explained by the fact that men
are exposed to the CVD risk factors early in the life than
women. Even though CHD and stroke have some com-
mon aspects, the reactivity of coronary and cerebral arter-
ies to the CVD risk factors, environmental and genetic
factors, has been found to differ [22]. Thus, as found in
the present study the known CVD risk factors including
diabetes may have contributed differently to the CHD and
the ischaemic stroke, and partly explained the gender dif-
ference in the risk of CHD and ischaemic stroke in dia-
betic individuals. However, when we interpret the results
we need to bear in mind that the number of ischaemic
stroke events in the present study was low, particularly in
the younger age groups both in women and in men.
The strengths of the present study are the long length of
follow-up and the pooled data from different cohorts,
which gave a large sample size and increased statistical
power. In order to make up for the differences in between
the different study centers all the analysis were adjusted
for "cohort". Even though the sample size was relatively
large, the follow-up length for many of the cohorts is still
short with low numbers of the events accumulated.
Conclusion
In summary, the CHD and ischaemic stroke risk was
higher in men than in women with and without diabetes,
however, the gender difference diminished for CHD butCardiovascular Diabetology 2009, 8:17 http://www.cardiab.com/content/8/1/17
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enlarged for ischaemic stroke in diabetic individuals. The
known risk factors including diabetes have contributed
differently to the development of CHD and ischaemic
stroke in women and men. The finding may help to make
strategies to manage diabetes, CHD and stroke in women
and in men.
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